Replimune Group, Inc. (REPL) Misses Q2 EPS by 5c

Replimune Group, Inc. (NASDAQ: REPL) reported Q2 EPS of ($0.79), $0.05 worse than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update
• Jefferies Downgrades United Spirits Ltd. (UNITDSPR:IN) to Hold